Jess Levins Kaplan MD
Pediatric Nutrition
Instructor in Pediatrics, Massachusetts General Hospital
Join to view full profile
101 Nicolls RdBoston, MA 11794
Phone+1 617-726-1450
Fax+1 617-726-5961
Dr. Kaplan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Pediatric Gastroenterology, 2008 - 2011- Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 2005 - 2008
University of Massachusetts Medical SchoolClass of 2005
Certifications & Licensure
CT State Medical License 2022 - 2027
MA State Medical License 2008 - 2027
NY State Medical License 2010 - 2023
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2016
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2016
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2016
Publications & Presentations
PubMed
- Aminosalicylate Use Increases Corticosteroid Exposure and Decreases Biologic Durability in Pediatric Crohn's Disease.Perseus V Patel, Jonathan Moses, Sabina Ali, David L Suskind, Brad Pasternak
Clinical Gastroenterology and Hepatology. 2026-08-22 - Treatment patterns among pediatric and adult patients with ulcerative colitis in the United States: a retrospective cohort study.Jess L Kaplan, Jennifer L Dotson, Theresa Hunter Gibble, Debbie Tinsley, Wallace V Crandall
Current Medical Research and Opinion. 2026-05-01 - 4 citationsEfficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomise...Jess L Kaplan, Athos Bousvaros, Dan Turner, Marla Dubinsky, Amy Larkin
The Lancet. Gastroenterology & Hepatology. 2026-02-01
Press Mentions
FDA Expands Stelara Approval to Pediatric Ulcerative ColitisAugust 31st, 2026
Mirikizumab Shows Promise for Kids with Ulcerative ColitisDecember 5th, 2025
Turning Lemons into LemonadeSeptember 7th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
